The Allergic Asthma Therapeutics Market is Trending by Growing Prevalence of Allergies

 

Allergic Asthma Therapeutics Market
Allergic Asthma Therapeutics Market 

The allergic asthma therapeutics market comprises anti-asthmatic and bronchodilator drugs that provide relief from symptoms caused due to asthma. These drugs work by relaxing airway muscles, reducing mucus production and swelling in airways. The growth in number of cases of allergic asthma due to rising environmental pollution and lifestyle changes has increased the demand for therapeutics which can effectively manage the condition.

The Global Allergic Asthma Therapeutics Market is estimated to be valued at US$ 8.37 Bn in 2024 and is expected to exhibit a CAGR of 13% over the forecast period 2024 to 2031.

Key Takeaways

Key players operating in the allergic asthma therapeutics are Ansarada Pty Ltd., Brainloop AG (Diligent Corporation), CapLinked, Citrix Systems Inc., Datasite Global Corporation, DealRoom Inc., EthosData, Firmex Inc, FORDATA sp. z o.o., iDeals Solutions Group, Intralinks Holdings Inc. (SS&C Technologies), SecureDocs Inc., ShareVault (Pandesa Corporation) and SmartRoom (BMC Group).

Rising air pollution levels, prevalence of Allergic Asthma Therapeutics Market Demand and changing lifestyle have increased the prevalence of allergic asthma over the years. This has boosted the demand for effective therapeutic drugs for treatment and management of the condition. Major companies are focusing on geographical expansion and new product launches to expand their market share and better serve patients across various countries.

Market key trends

Increasing research funding for development of novel biologic drugs for asthma is a key trend in the market. Biologics have potential to provide better management of allergic triggers and symptoms with reduced side effects as compared to conventional drugs. Regional governments and pharma companies are supporting research through funding and partnerships. Other major trends include growing adoption of digital health tools for asthma monitoring and management and home healthcare devices facilitating self-administration of drugs.

Porter’s Analysis

Threat of new entrants: Low barrier to entry due to easy availability of substitutes but high R&D costs for developing new therapies.

Bargaining power of buyers: Buyers have high bargaining power due to availability of substitute therapies but brand loyalty provides advantage to existing players.

Bargaining power of suppliers: Suppliers have moderate bargaining power due to availability of alternative suppliers of raw materials and presence of contracting organizations.

Threat of new substitutes: Substitutes present low threat as they treat different disease indications.

Competitive rivalry: High due to presence of many global and regional players.

Geographical Regions

North America accounts for the largest market share in terms of value due to high healthcare expenditure and increasing allergic asthma prevalence in the region.

Asia Pacific is poised to grow at the fastest rate during the forecast period driven by rising healthcare standards, growing medical tourism, and increasing investments by key players in the region.

Get More Insights On, Allergic Asthma Therapeutics Market

About Author:

Money Singh is a seasoned content writer with over four years of experience in the market research sector. Her expertise spans various industries, including food and beverages, biotechnology, chemical and materials, defense and aerospace, consumer goods, etc. (https://www.linkedin.com/in/money-singh-590844163)

Comments

Popular posts from this blog

In-Vehicle Payment Services: The Evolution of Vehicle Payment Services

Guidewires: Revolutionizing Medical Procedures

The Quantum Advantage: How Quantum Sensors Are Redefining Sensing Applications